ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 149

Deficiency of Complement C4A or Low Copy Number of Total C4 Genes, HLA-DRB1*15 and HLA-DRB1*03 Are Strong Genetic Risk Factors for Pediatric SLE of European Descent

Stacy Ardoin1, Pinar Ozge Avar Aydin2, Lai Hin Kimi Chan3, Katherine Lintner4, Yee Ling Wu5,6, Rabheh Aziz1, Anjali Patwardhan7,8, Evan Mulvihill1, Gakit Yu9, Bi Zhou10, Emeli Lundstrom11, Leonid Padyukov12, Kyla Driest13, Cagri Yildirim-Toruner13, Sharon Bout-Tabaku13, Charles Spencer14, Gloria Higgins1, Sampath Prahalad15, Hermine Brunner16 and Chack-Yung Yu10,17, 1Pediatrics and Rheumatology, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 2Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 3Pediatrics, Emory University School of Medicine, Atlanta, GA, 4Pediatrics, Nationwide Children's Hospital, Columbus, OH, 5The Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 6Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital, Columbus, OH, 7Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, 8Pediatric Rheumatology, Nationwide Children's Hospital, Columbia, MO, 9Center for Molecular and Human Genetics, Nationwide Children's Hospital, Columbus, OH, 10Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 11Rheumatology, Karolinska Institute, Stockholm, Switzerland, 12Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska Hospital, Stockholm, Sweden, 13Rheumatology, Nationwide Children's Hospital, Columbus, OH, 14Rheumatology, Nationwide Childrens Hospital/OSU, Columbus, OH, 15Pediatrics, Emory Children's Center, Atlanta, GA, 16Rheumatology, PRCSG, Cincinnati, OH, 17Pediatrics, Ohio State Univ, Columbus, OH

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: complement, complement deficiency and genetics, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Genetics and Pathogenesis Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:  A complete genetic deficiency of complement C4 almost always leads to the pathogenesis of systemic lupus erythematosus (SLE) with childhood onset, although its prevalence is extremely low. On the other hand, low gene copy number (GCN) of total C4 and genetic deficiency of C4A occur between 33 and 40% in adult SLE (aSLE) of European ancestry. Located centromeric to C4 on chromosome 6 is another SLE risk factor, specific alleles of HLA-DRB1. The objective of this study is to determine the effects of complement C4 gene copy number variations, C4A deficiency and HLA-DRB1 variants on the risk of pediatric SLE (pSLE).

Methods: Pediatric SLE patients and control subjects were recruited from Ohio and Atlanta, which included 105 Caucasian patients and 937 race-matched healthy subjects. The female to male ratio of pSLE was 5.7 to 1. GCNs of total C4, C4A, C4B, long and short C4 genes were determined by genomic Southern blot analyses, and/or TaqMan-based, quantitative realtime PCR using five amplicons. HLA-DRB1 variants were determined by 20 sets of specific PCR, and gel electrophoresis. Published data from 373 White aSLE were used for comparison.

Results:  The copy number of total C4 genes varies from 2 to 8 copies in a diploid genome. Each of those C4 genes may code for an acidic C4A or a basic C4B protein. Low GCN of total C4 (C4T≤3) was present in 45.7% of pSLE, 42.9% of aSLE and 28.4% of healthy controls. The odds ratios and 95% confidence interval for C4T≤3 was 2.1 (1.4-3.2) in pSLE (p=0.0004), and 1.9 (1.5-2.5) in aSLE (p=4.4×10-7). Homozygous and heterozygous deficiency of C4A (C4A≤1) occurred in 39.8% of pSLE, 32.7% of aSLE, and 18.6% of healthy controls. The odds ratios for C4A deficiency were 2.9 (1.6-4.9) in pSLE (p=2.6×10-6), and 2.1 (1.6-2.8) in aSLE (p=9.9×10-8). HLA-DRB1*15 (DR2) has a frequency of 45.7% in pSLE, 31.7% in aSLE and 27.9% in controls. The odds ratios of DRB1*15 were 2.2 (1.2-4.0) for pSLE (p=0.015), but only 1.2 (0.89-1.6) for aSLE (p=0.23). Another DRB1 allele *03 (DR3) had similar frequencies in pSLE (37.0%) and aSLE (38.6%), but a significantly lower frequency in controls (26.7%). Subjects with a homozygosity of C4A deficiency, or HLA-DRB1*15, or HLA-DRB1*03 together are present in 6.0% of healthy controls, but 26.7% of pSLE [OR=5.7 (2.7-12.2), p=4×10-5] and 15.9% of aSLE [OR=3.0 (1.9-4.70), p=2.5×10-6].

Conclusion:  C4A deficiency and low GCN of total C4 are significant risk factors for pediatric and adult SLE of European ancestry, but their effect sizes are consistently larger for pSLE. HLA-DRB1*15 plays an important role on the risk of pSLE. C4A deficiency, HLA-DRB1*15 and HLA-DRB1*03 have strong effects on conferring high risk of pSLE.


Disclosure: S. Ardoin, None; P. O. Avar Aydin, None; L. H. K. Chan, None; K. Lintner, None; Y. L. Wu, None; R. Aziz, None; A. Patwardhan, None; E. Mulvihill, None; G. Yu, None; B. Zhou, None; E. Lundstrom, None; L. Padyukov, None; K. Driest, None; C. Yildirim-Toruner, None; S. Bout-Tabaku, None; C. Spencer, None; G. Higgins, None; S. Prahalad, None; H. Brunner, None; C. Y. Yu, None.

To cite this abstract in AMA style:

Ardoin S, Avar Aydin PO, Chan LHK, Lintner K, Wu YL, Aziz R, Patwardhan A, Mulvihill E, Yu G, Zhou B, Lundstrom E, Padyukov L, Driest K, Yildirim-Toruner C, Bout-Tabaku S, Spencer C, Higgins G, Prahalad S, Brunner H, Yu CY. Deficiency of Complement C4A or Low Copy Number of Total C4 Genes, HLA-DRB1*15 and HLA-DRB1*03 Are Strong Genetic Risk Factors for Pediatric SLE of European Descent [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/deficiency-of-complement-c4a-or-low-copy-number-of-total-c4-genes-hla-drb115-and-hla-drb103-are-strong-genetic-risk-factors-for-pediatric-sle-of-european-descent/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deficiency-of-complement-c4a-or-low-copy-number-of-total-c4-genes-hla-drb115-and-hla-drb103-are-strong-genetic-risk-factors-for-pediatric-sle-of-european-descent/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology